RDH13 Inhibitors

Chemical inhibitors of RDH13 can exert their inhibitory effects through various mechanisms that disrupt the mitochondrial environment, an essential aspect for the proper function of RDH13. Menadione works by limiting the reduction of Vitamin K and related quinones, which are vital cofactors for RDH13's activity in the metabolism of retinoids. Warfarin, another inhibitor, impedes the regeneration of Vitamin K epoxide to its reduced form by inhibiting VKORC1, which in turn, could reduce the cofactor availability crucial for RDH13's proper function. Similarly, Chlorophenylhydrazone, by disrupting the mitochondrial membrane potential, can alter the optimal conditions required for RDH13 activity, given that RDH13 is mitochondrial in localization.

Furthermore, Omeprazole, through the inhibition of proton pumps, can lead to altered mitochondrial potential, indirectly impeding RDH13 function. Rotenone and Antimycin A are inhibitors of the mitochondrial electron transport chain at different complexes, which affect mitochondrial membrane potential, thereby influencing RDH13 activity. Thenoyltrifluoroacetone (TTFA) and its isomer, along with Carboxin, target mitochondrial complex II, and their inhibition of this complex can also shift the mitochondrial environment, resulting in reduced RDH13 activity. Atovaquone specifically inhibits the cytochrome bc1 complex, affecting RDH13 indirectly by altering its mitochondrial operating conditions. Sodium Azide acts on cytochrome c oxidase, leading to a change in mitochondrial function and membrane potential, crucial for RDH13's function. Amytal, targeting mitochondrial complex I, disrupts mitochondrial membrane potential, which is indispensable for RDH13, thereby inhibiting its enzymatic function in the mitochondria. Each of these chemicals, by targeting different aspects of mitochondrial physiology, can effectively lead to the functional inhibition of RDH13 by altering the specific environment it relies on for its activity.